Clearside Biomedical Company Insiders

Clearside Biomedical Management Team Effectiveness

The company has return on total asset (ROA) of (0.4846) % which means that it has lost $0.4846 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.1002) %, meaning that it created substantial loss on money invested by shareholders. Clearside Biomedical's management efficiency ratios could be used to measure how well Clearside Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 1.93, whereas Return On Tangible Assets are forecasted to decline to (0.90). At present, Clearside Biomedical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 15.8 M, whereas Non Currrent Assets Other are forecasted to decline to about 25.6 K. As of March 1, 2025, Common Stock Shares Outstanding is expected to decline to about 37.3 M. In addition to that, Net Loss is expected to decline to about (39.8 M)

Clearside Biomedical Workforce Comparison

Clearside Biomedical Insider Trading

Clearside Biomedical Notable Stakeholders

The success or failure of an entity such as Clearside Biomedical often depends on how effective the management is. Clearside Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Clearside management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Clearside management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Clearside Biomedical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clearside Biomedical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Clearside Biomedical's management manipulating its earnings.

When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.